Jean-Jacques Kiladjian/LinkedIn
Nov 24, 2025, 10:25
Jean Jacques Kiladjian Visits INSERM-supervised CIC 1408 Investigation Center
Jean Jacques Kiladjian, Head of Clinical Research Department of Inserm, shared on LinkedIn:
”A busy day visiting the INSERM-supervised CIC 1408 clinical investigation center in Saint-Etienne during its evaluation by HCERES, showcasing its dynamism and impressive scientific output in clinical pharmacology and public health, with a strong focus on vascular/hemostasis, immunomonitoring, inflammatory diseases (IBD and systemic), vaccinology, population health, paramedical research, and mental health.”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning